DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, presenting promising progress across various health care and industrial programs. With its structural similarity to By natural means derived human serum albumin, OsrHSA gives a safer, additional responsible alternative for therapeut